Reményhullámot váltott ki a világon, hogy karnyújtásnyira van a koronavírus elleni oltás » Biontech and Pfizer will supply 200 million doses of vaccine against COVID-19 EU

epa08814065 An undated handout picture made available by the German pharmaceutical company Biontec shows an ampoule with BNT162b2, the mRNA-based vaccine candidate against COVID-19, in Mainz, Germany. Pfizer and Biontech SE announced on 11 November 2020 that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against COVID-19 to European Union (EU) Member States, with an option for the European Commission to request an additional 100 million doses. EPA/BIONTECH SE / HANDOUT HANDOUT EDITORIAL USE ONLY/NO SALESElolvasom